Related by context. Frequent words. (Click for all words.) 72 MGCD# [001] 72 GRN#L 72 Phase 1b 71 Perifosine 71 Phase 2a trial 70 AP# [003] 70 ALN VSP 70 XL# [003] 70 belinostat 70 MDV# 70 antitumor activity 69 Phase Ib 69 Azixa 69 HspE7 69 RDEA# 69 voreloxin 69 pralatrexate 68 ofatumumab 68 RG# [001] 68 blinatumomab 67 IMGN# 67 LymphoStat B 67 picoplatin 67 hematological malignancies 67 perifosine 67 TREANDA 67 dose escalation 66 FOLOTYN 66 dose escalation trial 66 NGX# 66 INGN 66 vandetanib 66 elesclomol 66 ZYBRESTAT 66 metastatic renal cell carcinoma 66 phase IIb 66 PF # [001] 66 MGCD# [002] 66 PLX# 66 bortezomib 66 ENMD 66 DAVANAT R 66 INCB# [002] 65 Cotara 65 Phase 2a 65 ISIS # 65 Phase 2b trial 65 Atiprimod 65 Phase 2b study 65 dose limiting toxicities 65 TNFerade 65 ASA# 65 Marqibo 65 hematologic malignancies 65 ARRY 65 IDX# 64 sunitinib 64 Phase IIa trial 64 ONCONASE 64 solid tumors 64 randomized Phase 64 ALN RSV# 64 taxane 64 anticancer agents 64 HRPC 64 PRX # 64 Phase 2a clinical 64 AZD# 64 daclizumab 64 tolerated dose MTD 64 multiple ascending dose 64 CYT# 64 dasatinib 64 sorafenib 64 bevirimat 63 antiviral activity 63 Phase 2b clinical 63 Phase IIb clinical 63 satraplatin 63 resistant ovarian cancer 63 liver metastases 63 preclinical studies 63 AEZS 63 pharmacodynamic 63 T DM1 63 CUDC 63 monotherapy 63 Zerenex 63 CTCE 63 L MTP PE 63 dose escalation study 63 tesetaxel 63 kinase inhibitor 63 MOR# 63 CRx 63 APD# 63 Phase IIa clinical 63 NSCLC 63 evaluable patients 62 tivozanib 62 tamibarotene